Wolfgang Walther

Title: Wolfgang Walther: Innovator in Cancer Treatment

Introduction

Wolfgang Walther is a notable inventor based in Schwanebeck, Germany. He has made significant contributions to the field of cancer treatment, holding a total of 5 patents. His innovative approaches focus on methods to inhibit cancer metastasis and the use of advanced DNA constructs.

Latest Patents

One of Wolfgang Walther's latest patents involves the use of niclosamide for the treatment of cancer metastasis. This method identifies subjects at risk of metastasis by assessing elevated levels of S100A4 transcription. The treatment involves administering a therapeutically effective amount of niclosamide or its derivatives, with dosages ranging from 15 to 400 mg per kg of body weight, taken once or twice daily. Another significant patent relates to a DNA expression construct that features a dumbbell-shaped circular strand of deoxyribonucleic acids. This construct is designed for jet injection to treat cancer, incorporating a double-stranded stem and single-stranded loops, along with a promoter sequence, coding sequence, and termination signal.

Career Highlights

Throughout his career, Wolfgang Walther has worked with prominent organizations such as Mologen AG and the Max Delbrück Center for Molecular Medicine in Berlin-Buch. His work in these institutions has allowed him to advance his research and contribute to innovative cancer therapies.

Collaborations

Wolfgang has collaborated with esteemed colleagues, including Peter Michael Schlag and Ulrike Stein. These partnerships have further enriched his research and development efforts in the field of oncology.

Conclusion

Wolfgang Walther's contributions to cancer treatment through his innovative patents and collaborations highlight his role as a significant figure in medical research. His work continues to pave the way for advancements in cancer therapies.